|
Volumn 45, Issue 4, 2002, Pages 930-936
|
New strategy for antedrug application: Development of metalloproteinase inhibitors as antipsoriatic drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHIREGULIN;
ANTIPSORIASIS AGENT;
DNA FRAGMENT;
EPIDERMAL GROWTH FACTOR;
HEPARIN BINDING EPIDERMAL GROWTH FACTOR;
METALLOPROTEINASE INHIBITOR;
N HYDROXY 2 [(2,2 DIFLUOROETHOXY)(4 METHOXYPHENYL)PHOSPHORYL] 1,2,3,4 TETRAHYDROISOQUINOLINE 3 CARBOXAMIDE;
N HYDROXY 2 [(2,2,2 TRIFLUOROETHOXY)(4 METHOXYPHENYL)PHOSPHORYL] 1,2,3,4 TETRAHYDROISOQUINOLINE 3 CARBOXAMIDE;
PHORBOL 13 ACETATE 12 MYRISTATE;
PHOSPHONAMIDE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DRUG DECOMPOSITION;
DRUG SYNTHESIS;
ENZYME INHIBITION;
EPIDERMIS HYPERPLASIA;
HUMAN;
INFLAMMATION;
MOUSE;
NONHUMAN;
PLASMA;
PROTON NUCLEAR MAGNETIC RESONANCE;
PSORIASIS;
ANIMALS;
CELL LINE;
DISEASE MODELS, ANIMAL;
DRUG STABILITY;
EPIDERMAL GROWTH FACTOR;
GLYCOPROTEINS;
GROWTH SUBSTANCES;
HUMANS;
HYDROXYLAMINES;
HYPERPLASIA;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
ISOQUINOLINES;
MAGNETIC RESONANCE SPECTROSCOPY;
MATRIX METALLOPROTEINASE 1;
MATRIX METALLOPROTEINASE 3;
MATRIX METALLOPROTEINASE 9;
METALLOENDOPEPTIDASES;
MICE;
PROTEASE INHIBITORS;
PSORIASIS;
RECOMBINANT PROTEINS;
SKIN;
TETRADECANOYLPHORBOL ACETATE;
TETRAHYDROISOQUINOLINES;
|
EID: 0037075119
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm010349c Document Type: Article |
Times cited : (53)
|
References (32)
|